Effects of mass screening on age-specific incidence of neuroblastoma

International Journal of Cancer

Volumn 67, Issue 4, 1996, Pages 520-522

  Bessho, Fumio ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CHILD; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MASS SCREENING; NEUROBLASTOMA; PRIORITY JOURNAL;

AGE FACTORS; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; HUMANS; INCIDENCE; INFANT; JAPAN; MASS SCREENING; NEUROBLASTOMA; REGISTRIES; TIME;

EID: 0029809005     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960807)67:4<520::AID-IJC10>3.0.CO;2-B     Document Type: Article

References (28)

1. BESSHO, F., HASHIZUME, K., NAKAJO, T. and KAMOSHITA, S., Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J. Pediatr., 119, 237-241 (1991).
2. HAAS, D., ABLIN, A.R., MILLER, C., ZOGER, S. and MATTHAY, K.K., Complete pathologic maturation and regression of Stage-IVS neuroblastoma without treatment. Cancer, 62, 818-825 (1988).
3. HAYASHI, Y., INABA, T., HANADA, R. and YAMAMOTO, K., Chromosome findings and prognosis in 15 patients with neuroblastoma found by VMA mass screening. J. Pediatr., 112, 567-571 (1988).
4. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Five-year Report of Japan Children's Cancer Registry, Vol. I (1975), II (1983), III Children's Cancer Association of Japan, Tokyo (1987).
5. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Five-year Report of Japan Children's Cancer Registry, Vol. I (1975), II (1983), III Children's Cancer Association of Japan, Tokyo (1987).
6. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Five-year Report of Japan Children's Cancer Registry, Vol. I (1975), II (1983), III Children's Cancer Association of Japan, Tokyo (1987).
7. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
8. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
9. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
10. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
11. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
12. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
13. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
14. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
15. JAPAN CHILDREN'S CANCER REGISTRY COMMITTEE, Annual Reports of Japan Children's Cancer Registry. Pediat. Oncol., 22, 315-326 (1987); 24, 443-459 (1988); 26, 103-121 (1989); 27-2, 511-531 (1990); 28-3, 735-755 (1991); 29-2, 459-480 (1992); 30-1, 201-223 (1993); 31-1, 159-188 (1994); 32-1, 77-102 (1995).
16. KANEKO, Y., KANDA, N., MASEKI, N., NAKACHI, K., TAKEDA, T., OKABE, I. and SAKURAI, M., Current urinary screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J. clin. Oncol., 8, 2005-2013 (1990).
17. MAUER, A.M., Screening for neuroblastoma. J. Pediatr., 112, 576-577 (1988).
18. MURPHY, S.B., COHEN, S.L., CRAFT, A.W., WOODS, W.G., SAWADA, T., CASTLEBERRY, R.P., LEVY, H., PROROK, P.C. and HAMMOND, G.D., Do children benefit from mass screening for neuroblastoma? Lancet, 337, 344-345 (1991).
19. NISHI, M., MIYAKE, H., TAKEDA, T., YONEMORI, H., HANAI, J., KIKUCHI, Y. and TAKASUGI, N., Cases of spontaneous regression and true patients detected in mass screening for neuroblastoma. Int. J. Pediat. Hematol/Oncol., 1, 557-563 (1995).
20. PARKIN, D.M., Materials and methods of the study. In: D.M. Parkin, G.J. Draper, C.A. Bieber, B. Terracini and J.L. Young (eds.), International incidence of childhood cancer. IARC Scientific Publication 87, pp. 17-22, International Agency for Research on Cancer, Lyon (1988).
21. PARKIN, D.M., DRAPER, G.J., BIEBER, C.A., TERRACINI, B. and YOUNG, J.L. (eds.), International incidence of childhood cancer. IARC Scientific Publication 87, International Agency for Research on Cancer, Lyon (1988a).
22. PARKIN, D.M., STILLER, C.A., DRAPER, G.J. and BIEBER, C.A., The international incidence of childhood cancer. Int. J. Cancer, 42, 511-520 (1988b).
23. SAWAGUCHI, S., SUGANUMA, Y., WATANABE, I., TSUCHIDA, Y., OKABE, I., SAWADA, T., TAGUCHI, N., TAKAHASHI, H., KINUMAKI, H., ISE, Y., TSUNOOKA, A., TSUNOOKA, H., UEDA, T. and MUTA, H., Studies on the biological and clinical characteristics of neuroblastoma (I). Evaluation on the prognosis in relation to age and stage. J. Jap. Soc. pediat. Surg., 15, 1119-1127 (1979). (In Japanese with English abstract).
24. STILLER, C.A., Trends in neuroblastoma in Great Britain: incidence and mortality, 1971-1990. Europ. J. Cancer, 29A, 1008-1012 (1993).
25. TUCHMAN, M., LEMIEUX, B. and WOODS, W.G., Screening for neuroblastoma in infants: investigate or implement? Pediatrics, 86, 791-793 (1990).
26. UEDA, H., TANAKA, T., WATANABE, K., ARAMITSU, Y., HOGAKU, M., TASHIRO, S., KOBAYASHI, M. and UEDA, K., Myelodysplastic syndrome after treatment for neuroblastoma. J. Jap. Pediat. Soc., 99, 862-867 (1995). (In Japanese with English abstract).
27. WOODS, W.G. and TUCHMAN, M., Neuroblastoma: the case for screening infants in North America. Pediatrics, 79, 869-873 (1987).
28. YAMAMOTO, K., HANADA, R., HAYASHI, Y., KIKUCHI, A., ICHIKAWA, M. and TANIMURA, M., Population based incidence of neuroblastoma in Saitama Prefecture, Japan: effect of mass screening. In: Proceedings of 3rd International Symposium on Neuroblastoma Screening, pp. 24-27 (1994).